thalidomide has been researched along with Pain, Chronic in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to show the frequency, localisation, intensity, quality and degree of chronic pain in people with thalidomide-induced congenital defects (thalidomide embryopathy) and to investigate the association with biopsychosocial factors more closely." | 8.02 | [Chronic Pain in People Impaired by Thalidomide Embryopathy: An Explorative Analysis of Prevalence, Pain Parameters and Biopsychosocial Factors]. ( Albus, C; Lüngen, M; Niecke, A; Peters, KM; Pfaff, H; Ramesh, I; Samel, C, 2021) |
| "Lenalidomide is an analog of thalidomide with similar efficacy but improved side-effect profile." | 6.49 | Lenalidomide and thalidomide in the treatment of chronic pain. ( Asher, C; Furnish, T, 2013) |
| "The aim of the study was to show the frequency, localisation, intensity, quality and degree of chronic pain in people with thalidomide-induced congenital defects (thalidomide embryopathy) and to investigate the association with biopsychosocial factors more closely." | 4.02 | [Chronic Pain in People Impaired by Thalidomide Embryopathy: An Explorative Analysis of Prevalence, Pain Parameters and Biopsychosocial Factors]. ( Albus, C; Lüngen, M; Niecke, A; Peters, KM; Pfaff, H; Ramesh, I; Samel, C, 2021) |
| "Lenalidomide is an analog of thalidomide with similar efficacy but improved side-effect profile." | 2.49 | Lenalidomide and thalidomide in the treatment of chronic pain. ( Asher, C; Furnish, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niecke, A | 1 |
| Ramesh, I | 1 |
| Albus, C | 1 |
| Lüngen, M | 1 |
| Pfaff, H | 1 |
| Samel, C | 1 |
| Peters, KM | 1 |
| Asher, C | 1 |
| Furnish, T | 1 |
1 review available for thalidomide and Pain, Chronic
| Article | Year |
|---|---|
Lenalidomide and thalidomide in the treatment of chronic pain.
Topics: Anti-Inflammatory Agents; Chronic Pain; Drug-Related Side Effects and Adverse Reactions; Humans; Imm | 2013 |
1 other study available for thalidomide and Pain, Chronic
| Article | Year |
|---|---|
[Chronic Pain in People Impaired by Thalidomide Embryopathy: An Explorative Analysis of Prevalence, Pain Parameters and Biopsychosocial Factors].
Topics: Chronic Pain; Fetal Diseases; Humans; Prevalence; Surveys and Questionnaires; Thalidomide | 2021 |